Transmission of multidrug-resistant tuberculosis in the UK: A cross-sectional molecular and epidemiological study of clustering and contact tracing

The Lancet Infectious Diseases

Volumn 14, Issue 5, 2014, Pages 406-415

  Anderson, Laura F ^a   Tamne, Surinder ^a   Brown, Timothy ^a   Watson, John P ^b   Mullarkey, Catherine ^c   Zenner, Dominik ^a,d   Abubakar, Ibrahim ^a,d  

^a PUBLIC HEALTH ENGLAND   (United Kingdom)

^b LEEDS GENERAL INFIRMARY   (United Kingdom)

^c TB Health Visiting Service Leeds Community Healthcare   (United Kingdom)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ANTITUBERCULAR AGENTS; CHILD; CHILD, PRESCHOOL; CLUSTER ANALYSIS; CONTACT TRACING; DISEASE TRANSMISSION, INFECTIOUS; EPIDEMIOLOGIC STUDIES; FEMALE; GREAT BRITAIN; HUMANS; INFANT; LOGISTIC MODELS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; MOLECULAR EPIDEMIOLOGY; QUESTIONNAIRES; RISK FACTORS; TUBERCULOSIS, MULTIDRUG-RESISTANT; YOUNG ADULT;

EID: 84899455946     PISSN: 14733099     EISSN: 14744457     Source Type: Journal    
DOI: 10.1016/S1473-3099(14)70022-2     Document Type: Article

References (39)

1. Global tuberculosis report WHO, (accessed Jan 10, 2014). http://www.who.int/tb/publications/global_report/gtbr13_main_text.pdf.
2. Borrell S, Gagneux S Infectiousness, reproductive fitness and evolution of drug-resistant Mycobacterium tuberculosis. Int J Tuberc Lung Dis 2009, 13:1456-1466.
3. Pedrazzoli D, Anderson LF, Lalor M, et al. Tuberculosis in the UK: 2013 report (accessed Oct 17, 2013). http://www.hpa.org.uk/webc/HPAwebFile/HPAweb_C/1317139689583.
4. Kruijshaar ME, Watson JM, Drobniewski F, et al. Increasing antituberculosis drug resistance in the United Kingdom: analysis of National Surveillance Data. BMJ 2008, 31:1231-1234.
5. Abubakar I, Moore J, Drobniewski F, et al. Extensively drug-resistant tuberculosis in the UK: 1995 to 2007. Thorax 2009, 64:512-515.
6. Anderson LF, Moore J, Kruijshaar M, et al. Tuberculosis in the UK: annual report on tuberculosis surveillance in the UK, 2010 (accessed Oct 17, 2013). http://www.hpa.org.uk/webc/HPAwebFile/HPAweb_C/1287143594275.
7. Okereke E TB strain typing cluster investigation handbook for health protection units (accessed Oct 17, 2013). http://www.hpa.org.uk/webc/HPAwebFile/HPAweb_C/1317131018354.
8. Drobniewski FA, Caws M, Gibson A, et al. Modern laboratory diagnosis of tuberculosis. Lancet Infect Dis 2003, 3:141-147.
9. Brown TJ, Nikolayesskyy VN, Drobniewski FA Typing Mycobacterium tuberculosis using variable number tandem repeat analysis. Methods Molec Biol 2009, 465:371-394.
10. Brown TJ, Evans J, Sails A, et al. HPA Mycobacterium tuberculosis strain typing: a guide to data production and distribution (accessed Jan 10, 2014). http://www.hpa.org.uk/webc/HPAwebFile/HPAweb_C/1317135835628.
11. Gibson A, Brown T, Baker L, Drobniewski F Can 15-Locus Mycobacterial Interspersed Repetitive Unit-Variable-Number Tandem Repeat analysis provide insight into the evolution of Mycobacterium tuberculosis?. Appl Environ Microbiol 2005, 71:8207-8213.
12. Glynn JR, Vynnycky E, Fine PE Influence of sampling on estimates of clustering and recent transmission of Mycobacterium tuberculosis derived from DNA fingerprinting techniques. Am J Epidemiol 1999, 149:366-371.
13. Maguire H, Brailsford S, Carless J, et al. Large outbreak of isoniazid-monoresistant tuberculosis in London, 1995 to 2006: case-control study and recommendations. Euro Surveill 2011, 16. pii 19830.
14. Anderson LF, Tamne S, Watson JP, et al. Treatment outcome of multi-drug resistant tuberculosis in the United Kingdom: retrospective-prospective cohort study from 2004 to 2007. Euro Surveill 2013, 18. pii 20601.
15. Sintchenko V, Gilbert GL Utility of genotyping of Mycobacterium tuberculosis in the contact investigation: a decision analysis. Tuberculosis 2007, 87:176-184.
16. Broekmans JF, Migliori GB, Rieder HL, et al. European framework for tuberculosis control and elimination in countries with a low incidence. Recommendations of the World Health Organization (WHO), International Union Against Tuberculosis and Lung Disease (IUATLD) and Royal Netherlands Tuberculosis Association (KNCV) Working Group. Eur Respir J 2002, 19:765-775.
17. Diel R, Loddenkemper R, Zellweger JP Old ideas to innovate tuberculosis control: preventive treatment to achieve elimination. Eur Respir J 2013, 42:785-801.
18. Metcalfe JZ, Kim EY, Lin SY, et al. Determinants of multidrug-resistant tuberculosis clusters, California, USA, 2004-2007. Emerg Infect Dis 2010, 16:1403-1409.
19. Moonan PK, Teeter LD, Salcedo K, et al. Transmission of multidrug-resistant tuberculosis in the USA: a cross-sectional study. Lancet Infect Dis 2013, 13:777-784.
20. Devaux I, Kremer K, Heersma H, et al. Clusters of multidrug-resistant Mycobacterium tuberculosis cases, Europe. Emerg Infect Dis 2009, 15:1052-1060.
21. Fitzgibbon M, Gibbons N, Roycroft E A snapshot of genetic lineages of Mycobacterium tuberculosis in Ireland over a two-year period, 2010 and 2011. Euro Surveill 2013, 18. pii 20367.
22. Streicher EM, Muller B, Chihota V, et al. Emergence and treatment of multidrug resistant (MDR) and extensively drug-resistant (XDR) tuberculosis in South Africa. Infect Genet Evol 2012, 12:686-694.
23. Stagg HR, Cohen T, Becerra MC, Anderson LF, Abubakar I A tale of two settings: the role of the Beijing genotype in the epidemiology of MDR-TB. Eur Respir J 2013, published online Sept 13. 10.1183/09031936.00140513.
24. Filliol AS, Motiwala M, Cavatore W, et al. Global phylogeny of Mycobacterium tuberculosis based on single nucleotide polymorphism (SNP) analysis: insights into tuberculosis evolution, phylogenetic accuracy of other DNA fingerprinting systems, and recommendations for a minimal standard SNP set. J Bacteriol 2006, 188:759-772.
25. Clinical diagnosis and management of tuberculosis, and measures for its prevention and control National Institute Health and Care Excellence, (accessed Oct 17, 2013). http://www.nice.org.uk/CG033.
26. Fox G, Barry S, Britton W, et al. Contact investigation for tuberculosis: a systematic review and meta-analysis. Eur Respir J 2013, 41:140-156.
27. Duarte R, Neto M, Carvalho A, Barros H Improving tuberculosis contact tracing: the role of evaluations in the home and workplace. Int J Tuberc Lung Dis 2012, 16:55-59.
28. Reichler MR, Etkind S, Taylor Z, Castro KG Tuberculosis contact investigations. Int J Tuberc Lung Dis 2003, 7:S325-S327.
29. Perri BR, Proops D, Moonan PK, et al. Mycobacterium tuberculosis cluster with developing drug resistance, New York, New York, USA, 2003-2009. Emerg Infect Dis 2011, 17:372-378.
30. Erkens CG, Kamphorst M, Abubakar I, et al. Tuberculosis contact investigation in low prevalence countries: a European consensus. Eur Respir J 2010, 36:925-949.
31. Asghar RJ, Patlan DE, Miner MC, et al. Limited utility of name-based tuberculosis contact investigations among persons using illicit drugs: results of an outbreak investigation. J Urban Health 2009, 86:776-780.
32. Jit M, Stagg HR, Aldridge RW, White PJ, Abubakar I Dedicated outreach service for hard to reach patients with tuberculosis in London: observational study and economic evaluation. BMJ 2011, 14:343-354.
33. Cohen T, van Helden PD, Wilson D, et al. Mixed-strain Mycobacterium tuberculosis infections and the implications for tuberculosis treatment and control. Clin Microbiol Rev 2012, 25:708-719.
34. Cohen T, Murray M, Abubakar I, et al. Multiple introductions of multidrug-resistant tuberculosis into households, Lima, Peru. Emerg Infect Dis 2011, 17:969-975.
35. Behr M, Hopewell P, Paz E, et al. Predictive value of contact investigation for identifying recent transmission of Mycobacterium tuberculosis. Am J Respir Crit Care Med 1998, 158:465-469.
36. Guidelines for the programmatic management of drug-resistant tuberculosis. Emergency update 2008 WHO, (accessed Oct 17, 2013). http://whqlibdoc.who.int/publications/2008/9789241547581_eng.pdf.
37. MDR TB clinical advice service British Thoracic Society, (accessed Oct 17, 2013). http://www.brit-thoracic.org.uk/about-bts/bts-committees-and-advisory-groups/tuberculosis-specialist-advisory-group/.
38. Management of contacts of MDR TB and XDR TB patients European Centre for Disease Prevention and Control, (accessed Oct 17, 2013). http://www.ecdc.europa.eu/en/publications/publications/201203-guidance-mdr-tb-contacts.pdf.
39. Walker TM, Ip CL, Harrell RH, et al. Whole-genome sequencing to delineate Mycobacterium tuberculosis outbreaks: a retrospective observational study. Lancet Infect Dis 2013, 13:137-146.